Hannah Mamuszka
Directeur/Membre du Conseil chez BIONANO GENOMICS, INC.
Fortune : 6 368 $ au 31/05/2024
Profil
Hannah Mamuszka is the founder and the Chief Executive Officer of Alva10, Inc. (founded in 2016).
She is currently an Independent Director at Bionano Genomics, Inc. (since 2020).
Previously, she held the position of Director-Strategic Business Development at Asuragen, Inc. She was also the Director-Scientific & Pharmaceutical Alliances at Oncotech, Inc. from 2005 to 2012.
In addition, she served as a Director at Circle Cardiovascular Imaging, Inc. in 2021 and 2022.
Ms. Mamuszka has also worked as a Principal at Organogenesis, Inc. and Millennium Pharmaceuticals, Inc. She was the VP-Business Development & Clinical Strategy at Exosome Diagnostics, Inc. from 2010 to 2015.
Ms. Mamuszka holds a graduate degree from Harvard University and an undergraduate degree from the University of Maryland.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0,01% | 18/06/2024 | 6 579 ( 0,01% ) | 6 368 $ | 31/05/2024 |
Postes actifs de Hannah Mamuszka
| Sociétés | Poste | Début |
|---|---|---|
| BIONANO GENOMICS, INC. | Directeur/Membre du Conseil | 04/05/2020 |
| Alva10, Inc. | Directeur Général | 01/03/2016 |
Anciens postes connus de Hannah Mamuszka
| Sociétés | Poste | Fin |
|---|---|---|
Circle Cardiovascular Imaging, Inc.
 Circle Cardiovascular Imaging, Inc. Packaged SoftwareTechnology Services Circle Cardiovascular Imaging, Inc. develops and markets cardiac-image analytical software for the cardiac magnetic resonance and cardiac computed tomography industries. The firm's CMR and CCT images can provide a wealth of information about the patient?s cardiac condition such as functional parameters, flow and infarction. The company was founded by Greg Ogrodnick and Matthias Friedrich in 2007 and is headquartered in Calgary, Canada. | Directeur/Membre du Conseil | 01/06/2022 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/06/2015 |
Oncotech, Inc.
 Oncotech, Inc. Miscellaneous Commercial ServicesCommercial Services Oncotech, Inc. provides molecular oncology testing services. The firm's services improve the survival and quality of life of cancer patients through its molecular oncology testing services. Oncotech provides its testing services to hospitals in the US. The company was founded in 1985 and is headquartered in Tustin, CA. | Directeur Technique/Scientifique/R&D | 29/08/2012 |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Corporate Officer/Principal | - |
Formation de Hannah Mamuszka
| Harvard University | Graduate Degree |
| University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Oncotech, Inc.
Oncotech, Inc. Miscellaneous Commercial ServicesCommercial Services Oncotech, Inc. provides molecular oncology testing services. The firm's services improve the survival and quality of life of cancer patients through its molecular oncology testing services. Oncotech provides its testing services to hospitals in the US. The company was founded in 1985 and is headquartered in Tustin, CA. | Commercial Services |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Health Services |
| Alva10, Inc. | |
Circle Cardiovascular Imaging, Inc.
Circle Cardiovascular Imaging, Inc. Packaged SoftwareTechnology Services Circle Cardiovascular Imaging, Inc. develops and markets cardiac-image analytical software for the cardiac magnetic resonance and cardiac computed tomography industries. The firm's CMR and CCT images can provide a wealth of information about the patient?s cardiac condition such as functional parameters, flow and infarction. The company was founded by Greg Ogrodnick and Matthias Friedrich in 2007 and is headquartered in Calgary, Canada. | Technology Services |
